Conclusion
As orthopedic surgeons, we are all biased by our personal opinions and experiences. This is very evident when looking at the DVT prophylaxis patterns used by individual surgeons. Although comparing 30 years of DVT data is similar to comparing apples to oranges (or perhaps the entire fruit basket!), some trends have become evident. Recent well-designed studies discussed above cast doubt on the previous confidence in ASA and warfarin. Although no prophylaxis method is ideal, mechanical compression devices and low molecular weight heparin appear promising. Further studies are needed to evaluate this true DVT rate when these modalities are both utilized. Together, as is done at many institutions, the length of therapy required must also be better defined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Le Clerc JR, Geerts WH, Des Jardins L, La Flamme GH, L’Esperance BL, Demers C, Kassis J, Cruickshank M, Whitmore L, Delorme F. Prevention of venous thromboembolism after knee arthroplasty a randomized double blind trial comparing Enoxaparin with warfarin. ANN Intern Med. 1996; 124:619–626.
Pidala MJ, Donovan DL, Kepley RF. A prospective study on intermittent pneumatic compression in the prevention of deep vein thrombosis in patients undergoing total hip or total knee replacement. Surg-General-Obstet. 1992; 175: 47–51.
Anders MJ, Lifeso RM, Landis M, Mikulsky J, Meinking C, McCracken KS. Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee. J Bone Joint Surg. 1996; 78-A:574–580.
Sharrock NE, Sculco TP, Ranawat CS, Maynard MJ, Harpel PC. Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. J Arthroplasty. 1995; 10:523–526.
Stulberg BN, Francis CW, Pellegrini VD, Miller ML, Shull S, DeSwart R, Easley K, Totterman S, Marden VJ. Antithrombin III/low dose heparin in the prevention of deep vein thrombosis after total knee arthroplasty. Clin Orthop. 1989; 248:152–157.
Sharrock NE, Hargett MJ, Urquhart B, Peterson MGE, Ranawat C, Insall J, Windsor R. Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty. 1993; 8:133–139.
Kim YH. The incidence of deep vein thrombosis after cementless and cemented knee replacement. J Bone Joint Surg. 1990; 72:779–783.
Liu GC, Ferris EJ, Reifsteck JR, et al. Effect of anatomical variations on deep vein thrombosis of the lower extremity. Am J Roentgenol. 1986; 146:845–848.
Virchow R. Neuer Fall von Todticher, Embolie der Lungenarterien 1856. Arch Pathol Anat. 10:225–228.
Ginsberg JS, Brill-Edwards P, Panju A, Patel A, McGinnis J, Smith F, Dale I, Johnston M, Ofosu F. Preoperative plasma levels of thrombin-antithrombin II complex correlate with the development of venous thrombosis after major hip or knee surgery. Thrombosis and Haemostasis. 1995; 74:602–605.
Stulberg BW, Lucas FV, Belhobek GU. Anti-thrombin III as a marker of venous thromboembolism: a preliminary report. Trans Orthop Res Soc. 1984; 9:100.
Morrey BF. Joint Replacement Arthroplasty. New York: Churchill Livingston; 1991:67–82.
Lambie JM, et al. Diagnostic accuracy in venous thrombosis. Br Med J. 1970; 2:142–143.
Canale ST. Campbell’s Operative Orthopaedics. St. Louis: Mosby; 1998:270–285.
Albrechtsson U, Olsson CG. Thrombotic side effects of lower limb venography. Lancet. 1976; 1:723–724.
Thomas ML, MacDonald LM. Complications of ascending phlebography of the leg. Br Med J. 1978; 2:317–318.
Borris LC, Christiansen HM, Lassen MR, et al. Comparison of real time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. Thromb Haemost. 1989; 61:363–365.
Sadler DA. Diagnosis of deep-vein thrombosis comparison of clinical evaluation, ultrasound, plethysmography and venoscan with x-ray venogram. Lancet. 1984;716–719.
Harris WH, Athanasoulis C, Waltman AC, Salzman EW. Cuff-impedance phlebography and 125I fibrinogen scanning versus roentenographic phlebography for diagnosis of thrombophlebitis following hip surgery. J Bone Joint Surg. Am. 1976; 58(7):938–944.
Mullick SC, Wheeler HB, Songser GF. Diagnosis of deep venous thrombosis by measurement of electrical impedance. Am J of Surg. 1970; 119:417–423.
Lotke PQ, Palevsky H, Keenan AM, Meranze S, Steingerg ME, Ecker ML, Kelly MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop. 1996; 324:251–258.
Haas SB, Tribos CB, Insall JN, Becker MW, Windsor RE. The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg Br. 1992; 74(B)-6:799–802.
Philbrick T, Becker DM. Calf deep venous thrombosis-a wolf in sheep’s clothing? Arch Intern Med. 1988; 148:2131–2138.
Mudge M, Hughes LE. The long-term sequelae of deep vein thrombosis. Br J Surg. 1978; 65:692–694.
Warwick D, Perez J, Vicker C, Bannister G. Does total hip arthroplasty predispose to chronic venous insufficiency. J Arthrop. 1996; II(5):529–533.
Hedner T, Everts B. The early clinical history of salicylates in rheumatology and pain. Clin Rheumatol. 1998; 17(1): 17–25.
Mann CC, Plummer ML. The Aspirin Wars: Money, Medicine and 100 Years of Ramant Competition. New York: Knopf; 1991.
George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. NEJM. 1991; 324(I): 27–35.
Craven LL. Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Mississippi Valley Med J. 1953; 75:38–42.
Weiss HJ, Aledort LM, Kockwa S. The effect of salcylates on the hemostatic properties of platelets in man. J Clin Invest. 1986; 47:2169–2180.
Mustard JF, Packham MA. Factors influencing platelet function: adhesion, release and aggregation. Pharmacol Rev. 1970; 22:97–187.
DeLee JC, Rockwood CA. The use of aspirin in thromboemboli disease. J Bone Joint Surg 1980; 62(A):149–152.
Salzman EW, Harris WH, DeSanctis RW. Reduction in venous thromboembolism by agents affecting platelet function. NEJM. 1971; 284:1287–1292.
Patrono C. Aspirin as an antiplatelet drug. NEJM. 1994; 330(18):1287–1294.
Roth GJ, Calverley DC. Aspirin, platelets and thrombosis: theory and practice. Blood. 1994; 83(4):885–989.
Campbell WB. Lipid-derived autocoids: eicosanoids and platelet activation factor. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990.
McKenna R, Bachmann F, Kaushal SP, Galante JO. Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg. 1976; 58-A:928–932.
McKenna R, Galante J, Bachmann F, et al. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med Journal. 1980; 280:514–517.
Haas SB, Insall JB, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg. 1990; 72-A:27–31.
Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. J Bone Joint Surg. 78A (6):826–834.
Hirsh J, Dalen JE, Deykin E, et al. Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Chest. 1992; 102(supp 4):312S–326S.
O’Reilly RA. Lack of effect of fortified wine injested during fasting and anticoagulant therapy. Arch Intern Med. 1981; 141:458–459.
O’Reilly, Aggeler PM, Hoag MS, et al. Hereditary transmission of exceptional resistance to coumadin anticoagulant drugs. NEJM. 1983; 308:1229–1230.
Lieberman JR, Gererts WH. Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg. 1976; 58(A)(7):903–913.
Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop. 1987; 219:158–162.
Shorr RI, Ray WA, Daugherty JR, Griffin MR. Current use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Inter Med. 1993; 153:165–170.
Laflamme GH, Laflamme GE, Paiment, Beaumont P. Efficacy and safety of low dose warfarin prophylaxis in cemented total knee prosthesis. Ann Chir. 1994; 48(8):717–722.
Lotke PQ, Palevsky H, Keenan MA, Meranze S, Steingerg ME, Ecker ML, Kelly MA. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop. 1996; 324:251–258.
Hodge WA. Prevention of deep vein thrombosis after total knee arthroplasty. Clin Orthop. 1991; 271:101–105.
Clasett TP, Anderson FA Jr, Heit J, et al. Prevention of venous thromboembolism. Chest. 1995; 108(suppl):3125–3345.
Salzman EW, Harris WH. Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg. 1976; 58A(7):903–913.
Allenby F, Boardman L, Pflug J, Calnan J. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet. 1973; 2:1412–1414.
Weitz J, Michelsen J, Gold K, Owen J, Carpenter D. Effects of intermittent pneumatic calf compression on postoperative thrombin and plasmin activity. Thromb and Haemost. 1986; 56:198–201.
Gardner AM, Fox RH. The venous pump of the human foot: preliminary report. Bristol Med Chir J. 1983; 98:109–114.
Wilson NV, Das SK, Maurice H, et al. Thrombosis prophylaxis in total knee replacement. Br J Surg. 1992; 74(1): 50–52.
Wilson NV, Das SK, Smibert MG, Thomas EM, Kakkar VV. Thrombosis prophylaxis in total knee replacement: does a simple mechanical method help? Br J Surg. 1992; 77(12):1417.
Zimlich RH, Fulbright M, Friedman RJ. Current status on anticoagulation therapy after total hip and total knee arthroplasty. JAAOS. 1996; 4(1):54–62.
RD Heparin Arthroplasty Group. RD heparin compared with warfarin for the prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am. 1994; 76:1174–1185.
Heit J, Berkowitz S, Bona R, Comp P, Corson J, Cushner F, Ellio G, Garino J, Lyons R, Ohar J, Holloway S, Zacquis L. Efficacy and safety of Normiflo (A LMWH) compared to warfarin for prevention of venous thromboembolism following total knee replacement: a doubleblind dose-ranging study. Thromb Haemost. 1997; 77(1): 32–38.
Hull R, Raskob G, Brant R. A comparison of subcutaneous low-molecular weight heparin with warfarin for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med. 1993; 329(19):1370–1376.
Levine MN, Gent M, Hirsh J, Wertz J, et al. Ardeparin (low molecular weight heparin) vs. graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Arch Intern Med. 1996; 156:851–856.
Leclerc JR, Geerts WH, DesJardins L, et al. Prevention of deep vein thrombosis after major knee surgery: a randomized double blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost. 1992; 67:417–423.
Leclerc JR, Geerts WN, DesJardins L, I’Esporance B, Cruikshank M, et al. Prevention of venous thromboembolism (WTE) after knee arthroplasty-a randomized double-blind trial comparing a low molecular-weight heparin fragment (enoxaparin) to warfarin. Ann Int Med. 1996; 124(7): 619–626.
Spiro TE, Fitzgerald RH, Trowbridge AA, et al. Enoxaparin a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery. Blood. 1993; 82:410A (abstract).
Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep vein thrombosis following total knee replacement. J Bone Joint Surg. 1984; 66A(2):194–201.
Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop. 1987; 219:158–162.
Ansari S, Warwick D, Ackroyd CE, Newman MA. Incidence of fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation except in high risk cases. J Arthrop. 1997; 12(C):599–602.
Uresilovic EJ, Hozack WJ, Booth RE, Rothman RN. Incidence of pulmonary embolism after total knee arthroplasty with low dose coumadin prophylaxis. Clin Orthop. 1993; (286):27–31.
Petersdorf RG. Harrison’s Principles of Internal Medicine. Aukland: McGraw-Hill; 1983:1565.
Sabiston DC. Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 15th ed. W.B. Saunders Co.; 1997: 1602–1606.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Cushner, G.B., Cushner, F.D., Cushner, M.A. (2002). Deep Vein Thrombosis (DVT) and Total Knee Arthroplasty. In: Scuderi, G.R., Tria, A.J. (eds) Surgical Techniques in Total Knee Arthroplasty. Springer, New York, NY. https://doi.org/10.1007/0-387-21714-2_92
Download citation
DOI: https://doi.org/10.1007/0-387-21714-2_92
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-98389-9
Online ISBN: 978-0-387-21714-7
eBook Packages: Springer Book Archive